Literature DB >> 23891611

Do therapeutic bile acids hit the sweet spot of glucose metabolism in NAFLD?

Saul J Karpen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23891611     DOI: 10.1053/j.gastro.2013.07.017

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

Review 1.  NAFLD/NASH in patients with type 2 diabetes and related treatment options.

Authors:  M G Radaelli; F Martucci; S Perra; S Accornero; G Castoldi; G Lattuada; G Manzoni; G Perseghin
Journal:  J Endocrinol Invest       Date:  2017-11-30       Impact factor: 4.256

2.  Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.

Authors:  Brent A Neuschwander-Tetri; Rohit Loomba; Arun J Sanyal; Joel E Lavine; Mark L Van Natta; Manal F Abdelmalek; Naga Chalasani; Srinivasan Dasarathy; Anna Mae Diehl; Bilal Hameed; Kris V Kowdley; Arthur McCullough; Norah Terrault; Jeanne M Clark; James Tonascia; Elizabeth M Brunt; David E Kleiner; Edward Doo
Journal:  Lancet       Date:  2014-11-07       Impact factor: 79.321

3.  Novel Bile Acid Therapies for Liver Disease.

Authors:  Saul J Karpen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-02

4.  Bile acid signaling and bariatric surgery.

Authors:  Jingyan Tian; Silvia Huang; Siming Sun; Lili Ding; Eryun Zhang; Wendong Huang
Journal:  Liver Res       Date:  2017-12

5.  The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.

Authors:  Kazuya Okushin; Takeya Tsutsumi; Kenichiro Enooku; Hidetaka Fujinaga; Akira Kado; Junji Shibahara; Masashi Fukayama; Kyoji Moriya; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2015-11-25       Impact factor: 7.527

6.  L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease.

Authors:  Irina Voloshin; Michal Hahn-Obercyger; Sarit Anavi; Oren Tirosh
Journal:  Lipids Health Dis       Date:  2014-04-22       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.